CIAM
IDYA icon

Caitong International Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Caitong International Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-960
Closed -$32K – 3208
2026
Q1 		$32K Buy
+960
New +$32.2K 0.01% 902
2025
Q3 		– Sell
-193
Closed -$4.06K – 2210
2025
Q2 		$4.06K Sell
193
-1,366
-88% -$26.2K ﹤0.01% 1100
2025
Q1 		$25.5K Buy
1,559
+107
+7% +$2.28K 0.02% 700
2024
Q4 		$37.3K Buy
+1,452
New +$41.1K 0.04% 583

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Caitong International Asset Management's IDYA Position: Q2 2026 in Review

Caitong International Asset Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 960 shares — an estimated $32K sold.

Caitong International Asset Management first reported a position in IDYA in Q4 2024 and held it in 4 quarters. The position peaked at $37.3K in Q4 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Caitong International Asset Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 960 IDEAYA Biosciences shares in Q2 2026, an estimated $32K.
  • Caitong International Asset Management first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 4 quarters.
  • Caitong International Asset Management's IDEAYA Biosciences position peaked at $37.3K in Q4 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.